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Running Title: PEO mutation in POLG2 destabilizes pol γ 
  
  
3 
Abstract 
DNA polymerase γ is required to maintain the genetic integrity of the 16,569-base pair human 
mitochondrial genome (mtDNA).  Mutation of the nuclear gene for the catalytic subunit of pol γ (POLG) 
has been linked to a wide range of mitochondrial diseases involving mutation, deletion, and depletion of 
mtDNA.  We describe a heterozygous dominant mutation (c.1352G>A / p.G451E) in POLG2, the gene 
encoding the p55 accessory subunit of pol γ, which causes progressive external ophthalmoplegia with 
multiple mtDNA deletions and cytochrome c oxidase (COX) deficient muscle fibers.  Biochemical 
characterization of purified, recombinant G451E-substituted p55 protein in vitro revealed incomplete 
stimulation of the catalytic subunit due to compromised subunit interaction.  Although G451E p55 retains 
a wild type ability to bind DNA, it fails to enhance the DNA-binding strength of the p140•p55 complex.  
In vivo, the disease most likely arises through haplotype insufficiency or heterodimerization of the 
mutated and wild type proteins, which promote mtDNA deletions by stalling the DNA replication fork.  
The progressive accumulation of mtDNA deletions causes COX deficiency in muscle fibers and results in 
the clinical phenotype. 
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Introduction 
 Human mitochondrial DNA (mtDNA), which encodes 13 essential components of the respiratory 
chain, is replicated continuously in dividing cells and post-mitotic tissues.  Failure to preserve the genetic 
integrity of the mitochondrial genome during replication results in depletion, deletion, or mutation of 
mtDNA, which ultimately impair oxidative phosphorylation and cause cellular dysfunction and disease 1.  
The accuracy of mtDNA replication depends on the coordinated action of many nuclear-encoded proteins 
and the correct balance of nucleotides within the mitochondrial matrix.  Mitochondrial DNA is replicated 
by DNA polymerase γ (pol γ), which is composed of a 140-kDa catalytic subunit (p140) and a 55-kDa 
accessory subunit (p55) 2.  The catalytic subunit possesses DNA polymerase, 3’-5’ exonuclease, and 
5’dRP lyase activities, whereas the accessory subunit is a DNA binding factor that confers high 
processivity on the protein complex by increasing its affinity to DNA 3.  Mutations in the gene encoding 
the catalytic subunit (POLG) found on chromosome 15q25 cause dominant progressive external 
ophthalmoplegia (PEO, PEOA1 [MIM 157640] and  recessive PEO [MIM 258450]), Alpers syndrome 
[MIM 203700], as well as ataxia and peripheral neuropathy [MIM 607459] 4-11.  POLG mutations that 
cause PEO are linked to the formation of multiple mtDNA deletions in skeletal muscle.  Mutation of 
other nuclear genes involved in mtDNA replication and nucleotide metabolism, including the adenine 
nucleotide translocase (ANT1), the mtDNA helicase Twinkle (C10orf2), thymidine kinase 2 (TK2), 
deoxyguanosine kinase (DGUOK), and thymidine phosphorylase (TP), also cause human metabolic 
disorders accompanied by depletion and mutation of mtDNA.  However, the primary nuclear mutation 
remains undefined in many patients with secondary mtDNA defects 12.  Given the essential role of the 
p55 accessory subunit for highly processive mtDNA synthesis and enhanced DNA binding by the pol γ 
holoenzyme 3, POLG2 on chromosome 17q is an obvious candidate gene for these patients. 
 Here we describe the identification and characterization of a novel point mutation in the POLG2 
gene associated with autosomal dominant PEO.  Biochemical characterization of the mutant form of p55 
reveals intermediate stimulation and restoration of salt tolerance, intermediate N-ethylmaleimide 
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protection assays, no enhancement of DNA-binding by the pol γ complex, and no significant physical or 
functional interaction of the mutant p55 with the catalytic subunit under physiological conditions. 
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Subjects and Methods 
Subjects 
We identified a female patient of 60 yrs of age who developed exercise intolerance and muscle 
pain by age 40, followed by progressive drooping of the eyelids (ptosis), PEO, and mild weakness of the 
facial and limb muscles.  She had impaired glucose tolerance, evidence of a cardiac conduction defect 
(left bundle branch block and intermittent bigeminy), a fasting blood lactate of 1.8 mM (normal <2), and 
a serum creatine kinase of 664 U/l (normal <170).  Her mother had been similarly affected but is 
deceased and her two sisters are unaffected.  The patient had two asymptomatic offspring in their 30s 
who declined assessment and further investigation. 
 
Mitochondrial studies and mtDNA molecular genetics 
Southern blot and long-range PCR of mtDNA was carried out on DNA extracted from a muscle 
homogenate from the index case using an established protocol amplifying a ~9.9 kb fragment across the 
major arc using the Expand Long Template PCR System (Roche, Indianapolis, IN) 13.  COX – succinate 
dehydrogenase (SDH) histochemistry was carried out on cryostat sections of the left quadriceps muscle 
biopsy.  The activity of individual respiratory chain complexes was determined relative to citrate 
synthase activity.  Cryostat muscle sections were also cut and stained on membrane slides for laser 
microdissection (Leica ASLMD, Milton Keynes, UK).  Each cell was lysed and both the total amount of 
mtDNA and the amount of non-deleted mtDNA was quantified in each fiber by real-time PCR using iQTM 
Sybr Green on the BioRad ICycler (BioRad, Hercules, CA) 14.  Total mtDNA was determined in triplicate 
on a single cell from a target template spanning from nt 3459 to nt 3569 of the mtDNA MTND1 gene.  
Non-deleted mtDNA was determined in triplicate on a single cell from a target template spanning from nt 
11145 to nt 11251 of the mtDNA MTND4 gene.  The results were expressed as the percentage of deleted 
mtDNA by convention 15. 
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Molecular Genetics 
Total DNA was extracted by standard methods from either muscle or blood from 100 patients 
with sporadic or familial PEO with histochemical evidence of mitochondrial disease (COX deficient 
muscle fibers and/or ragged-red fibers in greater proportions than would be expected for age-matched 
healthy controls 16 and multiple deletions in skeletal muscle demonstrated with at least two of the 
following methods: Southern blot, long-range-PCR, and real-time PCR 15).  POLG2 was sequenced using 
published primer sequences incorporating forward and reverse –M13 tags, a fluorescent chain 
terminating sequencing kit (Beckman Coulter Quickstart, Fullerton, CA) and a Beckman Coulter CEQ 
8000 fluorescent DNA analyzer.  Sequences were analyzed using Bioedit (v.509) sequence alignment 
editor, against reference sequences (Genbank; POLG2 NM_007215).  144 healthy control subjects (288 
control chromosomes) were screened for the 1352G>A mutation by denaturing high performance liquid 
chromatography (DHPLC) of exon 8 PCR products generated from the sequencing primers (Tm 57˚C, 
Transgenomic 3500HT WAVE system using a standard solvent gradient, melt temperature 60.6˚C, buffer 
B 59.8%). 
 
Proteins 
The catalytic subunit of human pol γ was overexpressed in baculovirus-infected Sf9 cells and 
purified to homogeneity, as described previously 17, 18.  Several modifications were made to the plasmid 
bearing the recombinant accessory subunit.  The coding sequence was transferred from pQESL-Hp55 3 to 
a pET-based expression vector and the N-terminal (His)6 affinity-tag was removed.  The new N-terminal 
amino acid sequence was Met1-Asp26-Ala27-Gly28, which deletes the N-terminal 25 amino acids that 
compose the mitochondrial targeting sequence 3.  The amino acids Ser-(His)6 were added to the C-
terminus to incorporate a new affinity-tag.  Additionally, the QuikChange site-directed mutagenesis kit 
(Stratagene, La Jolla, CA) was utilized to change seven rare codons (Arg36 from AGG to CGT, Pro39 
from CCC to CCG, Gly41 from GGA to GGT, Arg75 from AGA to CGT, Arg76 from AGG to CGT, Leu79 
  
  
8 
from CTA to CTG, and Gly81 from GGA to GGT) to optimize translation in E. coli.  DNA sequencing 
open reading frame of the resulting plasmid (pET-p55CHIS) confirmed the G451E substitution and also 
revealed a synonymous CTG to TTG mutation at Leu codon 347 in the mutant construct, which is not 
expected to affect the recombinant protein.  The G451E derivative of p55 was constructed by site-
directed mutagenesis, utilizing pET-p55CHIS as the template and the mutagenic primers 5'-CT ACT 
TTG GAG AAT GAA TTA ATA CAT CTG A-3' and 5'-T CAG ATG TAT TAA TTC ATT CTC CAA 
AGT AG-3' (Oligos Etc., Inc., Wilsonville, OR).  DNA sequencing confirmed the G451E substitution 
and also revealed a synonymous CTG to TTG mutation at Leu codon 347 in the mutant construct, which 
is not expected to affect the recombinant protein.  E. coli BL21(DE3) that had been transformed with a 
plasmid expressing either WT p55 or G451E p55 was grown at 37˚C in 1.5 L of Luria-Bertani media 
containing 100 µg/ml ampicillin to an OD595 of 1.0, then cultures were chilled to 30˚C and induced for 13 
hours with 1 mM isopropyl thiogalactoside.  Cells were harvested by centrifugation, washed once with 
10 mM HEPES (pH 7.1) and 50 mM NaCl, frozen with liquid nitrogen, and stored at –80˚C.  Both WT 
p55 and G451E p55 were purified to homogeneity from frozen cell pellets as described 3, except the 
Triton X-100 in the third wash buffer for Ni-NTA agarose chromatography was replaced with 0.01% NP-
40.  Whereas the N-terminal (His)6-tagged p55 protein eluted from a MonoS column at ~0.54 M NaCl 3, 
both the WT and G451E C-terminal (His)6-tagged derivatives eluted from MonoS at 0.34 M NaCl.  
Codon optimization enhanced protein production 4- to 10-fold relative to the original construct, 
permitting purification of up to 1.5 mg p55 (Fraction IV) from each liter of culture media.  For the 
current study, both forms of p55 (Fraction IV) were transferred into a buffer containing 10 mM HEPES 
(pH 7.4), 0.15 M NaCl, 3 mM EDTA, 0.005% Surfactant P20 (Polysorbate 20) by passage through a 5 
mL HiTrap Desalting column (Amersham Biosciences, Piscataway, NJ) prior to freezing with liquid 
nitrogen and storage at -80˚C. 
 
Enzymatic assays 
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DNA polymerase activity was determined as described and utilized poly(rA)-oligo(dT)12-18 
(Amersham Biosciences, Piscataway, NJ) as the substrate 3.  The two subunit form of pol γ was 
reconstituted as described 3, and reactions contained the indicated quantities of NaCl and/or the inhibitor 
N-ethylmaleimide (NEM).  The processivity of polymerase γ was determined by monitoring extension of 
a 5’-end labeled oligonucleotide primer hybridized to M13mp18 DNA, as previously described 19.  
Reaction products were resolved by denaturing polyacrylamide gel electrophoresis and alkaline agarose 
gel electrophoresis 3 and visualized with a Typhoon 9400 PhosphorImager (Molecular Dynamics, 
Piscataway, NJ) and NIH Image 1.63 software. 
 
Analytical DNA-cellulose chromatography 
A 1 mL column of single-stranded DNA-cellulose (Sigma) was equilibrated at 4˚C in 0.025 M 
Tris-Cl (pH 7.5), 10% glycerol, 1 mM 2-mercaptoethanol, 0.1 mM EDTA (Buffer A) also containing 
0.025 M NaCl.  Samples of purified recombinant p140, WT p55 and G451E p55 were adjusted by 
dilution to the ionic strength of this buffer and applied to the column, which was washed with 9.5 mL of 
equilibration buffer and developed with a 15 mL linear gradient of NaCl (0.025-0.6 M) in Buffer A.  
Samples of each gradient fraction were analyzed by SDS-PAGE on 4-20% gradient gels (Invitrogen, 
Carlsbad, CA) using a Tris-glycine buffer system, and proteins were stained with Coomassie Brilliant 
Blue. 
 
Immunoprecipitation assay 
Rabbit polyclonal antibodies (DPg) against recombinant pol γ 17 were immobilized on Protein G-
Sepharose beads (Amersham Biosciences, Piscataway, NJ), and the beads were then equilibrated in 
PBSN-BSA buffer consisting of 0.05 M KPO4 (pH 7.5), 0.15 M NaCl, 0.1% NP-40, and 0.1 mg/mL 
BSA.  Prepared DPg-Protein G-Sepharose beads (10 µL) were mixed with purified wild type pol γ (3 µg), 
A467T mutant pol γ (3 µg), and/or the p55 accessory subunit (3 µg), as indicated, in a 1.5 mL 
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polypropylene microfuge tube and brought to a final volume of 0.4 mL with PBSN-BSA.  Tubes were 
rotated end-over-end for 45 min at 4˚C, and beads were collected by microcentrifugation at 5000 rpm for 
2 min at 4˚C.  The supernatant was removed and beads were washed twice with PBSN-BSA and once 
with PBSN lacking BSA.  Beads were resuspended in 25 µL 2x LDS loading buffer (4x LDS loading 
buffer from Invitrogen, made 2x with PBSN lacking BSA), and the samples were heated for 10 min at 
70˚C prior to analysis on 4-12% NuPage Bis-Tris polyacrylamide gels (Invitrogen, Carlsbad, CA).  After 
electrophoresis, the proteins were electrotransferred to an Immobilon-P PVDF membrane (Millipore, 
Bedford, MA).  The membrane was then washed in TNT (0.1% Triton X-100, 50 mM Tris-HCl (pH 7.5), 
0.5 M NaCl) for 15 min and blocked with 5% dried milk in TN (50 mM Tris-HCl (pH 7.5), 0.5 M NaCl) 
at room temperature.  The blot was incubated with 0.2 µg/mL anti-Penta-His monoclonal antibody 
(Qiagen, Valencia, CA) in TN containing 0.1 mg/mL BSA for 2 hr, washed 3 times with TN for 10 min, 
and incubated in a 1/3000 dilution of goat anti-mouse alkaline phosphatase conjugated secondary 
antibody (Bio-Rad, Hercules, CA) for 1 hr.  Following three 10 min washes in TNT and three 10 min 
washes in TN, bands were visualized with Western Blue reagent (Promega, Madison, WI). 
 
Other methods 
Protein concentration was determined relative to a bovine serum albumin standard, as described 
by Bradford 20. 
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Results 
Mitochondrial biochemistry and mtDNA analysis 
Skeletal muscle histochemistry on the index case revealed a mosaic cytochrome c oxidase (COX) 
defect with 6% COX-negative fibers (Fig. 1A).  Biochemical analysis of a skeletal muscle homogenate 
revealed normal respiratory chain complex activity.  Southern blot analysis and long-range PCR of 
skeletal muscle mtDNA revealed multiple mtDNA deletions (Fig. 1B).  Single muscle fiber real-time 
PCR detected high percentage levels of deleted mtDNA in the majority of COX-defective muscle fibers, 
typical of a multiple mtDNA deletion disorder (Fig 1C) 15. 
 
Identification of a heterozygous mutation in POLG2 
 Sequence analysis revealed no mutations in ANT1, C10orf2 and POLG.  Given the critical role of 
the p55 subunit in pol γ function in vitro, we sequenced the eight coding exons and adjacent intronic 
regions of POLG2 in this patient as well as 100 other patients with PEO and multiple mtDNA deletions 
in skeletal muscle known not to have mutations in ANT1, C10orf2 and POLG.  A single heterozygous 
transition (1352G>A) was identified in the patient described above, whereas her two unaffected sisters 
did not harbour the mutation (Figs. 2A and 2B).  The mutation was not detected in 288 control 
chromosomes from the same geographic region by DHPLC analysis (Fig. 2C).  The 1352G>A mutation 
is predicted to alter a highly conserved glycine to glutamate at codon 451 (G451E, Fig. 2D). 
 
Reduced stimulation of p140 by G451E p55 
 Given the central role of p55 in mitochondrial DNA replication, we tested whether the 
phenotypic changes caused by the G451E substitution would also result in measurable biochemical 
defects.  In order to compare the biochemical properties of WT p55 and G451E p55, both forms of the 
protein lacking the mitochondrial targeting sequence were over-produced in E. coli and purified to 
apparent homogeneity as described in Materials and Methods.  The catalytic activities of isolated p140 
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on natural DNA substrates are inhibited by physiological concentrations of salt, and association of p140 
with WT p55 both stimulates polymerase activity and significantly raises the ionic strength for optimal 
pol γ activity 17, 3.  The ability of G451E p55 to affect the polymerase activity of p140 on 
poly(rA)•oligo(dT) was assessed at a variety of salt concentrations (Fig. 3).  Whereas WT p55 stimulated 
p140 activity almost 3-fold and raised the salt optimum from ~75 mM to ~150 mM NaCl (compare 
squares and triangles, Fig. 3), the G451E form of p55 only enhanced polymerase activity ~2-fold with 
merely a 25 mM increase in the salt optimum (circles).  Neither protein was able to stimulate p140 in the 
absence of supplemental salt.  Because stimulation and restoration of salt tolerance by p55 occur through 
a mechanism of enhanced DNA-binding by the p140•p55 complex 3, we hypothesized that the incomplete 
stimulation and limited restoration of salt tolerance exhibited by G451E p55 were caused by altered 
DNA-binding by G451E p55 and/or an impaired interaction with the p140 catalytic subunit. 
 
DNA-binding by G451E p55 
 The wild type accessory subunit binds double-stranded DNA and folded single-stranded DNA 3, 
21
.  Single-stranded DNA-cellulose chromatography was utilized to measure the intrinsic strength with 
which WT p55 and G451E p55 bind to DNA (Fig. 4A).  As expected, WT p55 dissociated from the resin 
at 0.22 M NaCl (dashed line).  In a separate test G451E p55 also eluted at 0.22 M NaCl, demonstrating 
that the mutant protein retains the ability to bind DNA with the same strength as WT p55 (solid line).  
Elution of isolated p140 at ~0.20 M NaCl is also shown (dotted line).  Since the DNA binding properties 
and the chromatographic behavior during purification of G451E p55 were indistinguishable from that of 
WT p55, the analysis was extended to search for potential defects in subunit interaction.  When purified 
p140 and WT p55 were mixed briefly and applied to the DNA-cellulose column (Fig. 4B), more than half 
of the protein in the mixture bound the resin more tightly and eluted at ~0.32 M NaCl (dashed line) in 
fractions 19 and 20 (Fig. 4C).  The enhanced DNA-binding properties of this salt-stable pol γ complex 
has been documented previously 3.  In contrast, G451E p55 and p140 failed to form a more tightly 
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binding complex (solid line).  Instead, each protein in the mixture chromatographed independently, with 
peak elution of both proteins at 0.22 M NaCl in fractions 17 and 18 (Fig. 4D).  This apparent inability of 
the G451E p55 and p140 subunits to assemble into a pol γ holoenzyme complex prompted additional 
experiments to evaluate the functional and physical interactions of the subunits. 
 
G451E p55 exhibits reduced protection of p140 against inactivation by N-ethylmaleimide 
 N-ethylmaleimide (NEM) inhibits certain enzymes, including human pol γ, through covalent 
modification of solvent accessible cysteine residues.  Because cysteine has not been identified as a 
catalytic residue in any DNA polymerase, we presume that NEM inhibits pol γ by interfering with 
formation of a ternary complex between the enzyme, the primer-template, and the incoming dNTP 
substrate.  Association of p55 with p140 protects the catalytic subunit from inactivation by NEM 3, 22, and 
this protective effect has been utilized as a chemical probe to assess association of the pol γ subunits 19.  
Inhibition of pol γ at different concentrations of NEM was re-established in the standard polymerase 
assay in which 1.0 mM NEM inhibited the polymerase activity of isolated p140 by ~95% (Fig. 5).  Brief 
pre-incubation of p140 with a 2-fold molar excess of WT p55 protected greater than 80% of polymerase 
activity at all concentrations of NEM that were tested.  A reduced level of protection was observed upon 
pre-incubation with the mutant form of p55, and protection by G451E p55 was only 65-80% as effective 
as protection by WT p55 at NEM concentrations greater than 0.1 mM.  This intermediate protection of 
p140 against attack by NEM further supports the notion that the G451E substitution in p55 compromises 
association with the p140 subunit. 
 
Impaired subunit interaction revealed by failure to immunoprecipitate G451E subunit 
 Physical association of the subunits was evaluated further by immunoprecipitation assay.  Protein 
G-Sepharose beads were loaded with polyclonal antibodies raised against purified recombinant p140, 
washed thoroughly, and used to test the ability of immobilized p140 to capture the WT and mutant forms 
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of p55.  Co-immunoprecipitation of WT p55 with p140 was straightforward, and capture of p55 was 
clearly dependent on the presence of p140 (Fig. 6, lanes 1 and 2).  However, p140 was unable to capture 
an appreciable quantity of G451E p55 (lanes 3 and 4).  In separate control experiments, increasing 
available G451E p55 to 5 µg and increasing the amount of beads by 250% did not permit detection of 
G451E p55 in the immunoprecipitates (data not shown).  Failure to co-immunoprecipitate G451E p55 
further suggests a weakened interaction between the G451E form of p55 and the p140 subunit. 
 
G451E p55 fails to enhance the processivity of p140 
 Upon binding productively to primer-template DNA, the pol γ catalytic subunit exhibits moderate 
processivity by synthesizing 50-75 nucleotides prior to dissociating from the DNA 17.  Association of the 
wild type accessory subunit promotes tighter binding to DNA (Fig. 4), and reduced dissociation from the 
primer-template significantly increases the processivity of the pol γ complex to several thousand 
nucleotides 3.  Because processivity is a sensitive functional assessment of subunit interaction during 
DNA synthesis, the effects of G451E p55 on the processivity of p140 were measured in gel-based primer 
extension assays (Fig. 7).  Under reaction conditions that limit DNA binding events, the isolated p140 
subunit extended the primer by 75-100 nt at 0 mM NaCl (Fig. 7A, lane 1), and distinct pausing due to 
template secondary structure at ~50 and ~85 nt was apparent, as previously observed 17-19.  Primer 
extension activity of p140 was inhibited at 150 mM NaCl (lane 2).  Inclusion of WT p55 permitted 
primers to be extended by ~150 nt at low salt (lane 3).  Addition of 150 mM NaCl greatly reduced 
polymerase stalling near the primer, and roughly half the products became too large to enter the 
polyacrylamide gel (lane 4).  In contrast, G451E p55 was unable to stimulate primer extension by p140 at 
either salt concentration (compare lanes 1 and 2 to lanes 5 and 6).  Whereas physiological salt conditions 
are optimal for activity of the p140•WT p55 complex 3, 150 mM NaCl may be high enough to mask 
stimulation of p140 by G451E p55.  However, when the experiment was repeated at 75 mM NaCl, no 
stimulatory effect was observed for G451E p55 (data not shown).  Similarly, inclusion of a DNA trap in 
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the reactions to absolutely restrict pol γ to a single DNA binding event did not change our interpretation.  
Reaction products were also separated on alkaline agarose gels to more fully resolve the high molecular 
weight reaction products (Fig. 7B).  Again, isolated p140 was more active at low salt, and the shorter 
products were not well resolved by this method (lanes 1 and 2).  When in complex with WT p55, p140 
synthesized products as long as 7 kb or the full length of the M13 template (lanes 3 and 4).  The absence 
of high molecular weight primer extension products again demonstrates the failure of G451E p55 to 
enhance the processivity of p140 (lanes 5 and 6). 
 The dominant inheritance pattern suggests that G451E p55 may interfere with the natural 
function of WT p55 in vivo.  To investigate this possibility, primer extension assays were undertaken to 
search for a dominant negative biochemical effect in vitro.  Consistent with recent work indicating the 
pol γ holoenzyme may function as a heterotrimer 23, 24, reactions were made to contain two p55 subunits 
for every p140 subunit, and the processivity of DNA synthesis was monitored as the ratio of WT p55 and 
G451E p55 was varied.  Over a wide range of salt concentrations, the presence of G451E p55 did not 
diminish the stimulatory effects of WT p55 beyond that expected from simple dilution (data not shown).  
In separate experiments, increasing amounts of G451E p55 were titrated into standard reactions to test 
for inhibition of processive DNA synthesis catalyzed by p140•WT p55.  An 8-fold stoichiometric excess 
of G451E p55 had no effect on p140•WT p55 activity, suggesting that exchange of p55 subunits within 
the heterotrimer was not occurring in the 30 minute timeframe of the experiment.  Although the wild type 
component of p55 dimers within the mitochondria of an individual heterozygous for POLG2 cannot 
easily be determined, the failure of our mixing experiments to reveal a dominant negative effect in vitro 
suggests the phenotype of the affected heterozygote may be due to simple haploinsufficiency, as 
discussed below. 
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Discussion 
 This work describes the first example of a pathogenic mutation in POLG2.  Clinically the patient 
had typical late-onset PEO, with no specific clinical features that were different from the other 100 
patients screened for POLG2 mutations who had a wild-type sequence. One goal of this study was to 
identify biochemical defects in the G451E p55 that might help to explain the phenotypic changes caused 
by the G451E substitution in vivo.  Biochemical characterization of the purified, recombinant G451E p55 
protein in vitro revealed incomplete stimulation of the catalytic subunit and limited restoration of salt-
tolerant polymerase activity as compared to the effects of WT p55.  Although G451E p55 retains a wild 
type ability to bind DNA, it fails to enhance the DNA-binding strength of the p140•p55 complex.  A 
weakened subunit interaction between G451E p55 and p140 was further demonstrated by intermediate 
protection of p140 from inactivation with N-ethylmaleimide, by the failure of G451E p55 to co-
immunoprecipitate with p140, and by the inability of G451E p55 to enhance the processivity of p140.  
Previously we characterized a mutant form of the pol γ catalytic subunit associated with Alpers 
syndrome, juvenile spinocerebellar ataxia-epilepsy syndrome and recessive forms of PEO, and this 
pathogenic A467T substitution caused both a severe catalytic defect and interfered with association of 
the subunits 19.  Since the G451E substitution in p55 only disrupts association of the subunits, we propose 
that any mutation that impairs assembly of the pol γ holoenzyme is sufficient to stall the mtDNA 
replication fork, thereby inducing mtDNA deletions and the attendant disease phenotypes.  Additionally, 
the G451E mutation in POLG2 and pathogenic mutations in POLG offer a unique opportunity to define 
the p140•p55 subunit interface. 
 The proband in the current study is heterozygous for the G451E substitution in p55, prompting 
the simple assumption that haplotype insufficiency of POLG2 causes disease by reducing the availability 
of functional pol γ holoenzyme.  Such a partial loss of holoenzyme function is consistent with the 
delayed onset of symptoms (40 years) in the proband. In an extreme example of haplotype insufficiency 
that affects the bioavailability of pol γ we recently documented a similar gene dose effect for the pol γ 
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holoenzyme in which homozygous patients with two A467T POLG alleles usually present with late onset 
Alpers syndrome or early ataxia in their teens, whereas monoallelic expression of an A467T POLG allele 
was accompanied by very early onset of Alpers syndrome 25.  In contrast, evidence that the mother was 
similarly affected suggests autosomal dominant inheritance of PEO due to the G451E mutation in 
POLG2.  In this situation, the presence of the mutant G451E p55 should be able to interfere with the 
normal functions of wild type pol γ holoenzyme.  A dominant negative effect was not revealed by mixing 
experiments in vitro, which supports the notion that symptoms in affected heterozygotes are caused by 
haplotype insufficiency. 
 A more complex analysis involving physical and structural studies of pol γ also merits 
consideration.  The crystal structure of the mouse pol γ accessory subunit indicates that the isolated 
accessory subunit exists as a homodimer 23 (Fig. 8).  The structure shows that each monomer has three 
distinct domains where domain 1 consists of a 7-stranded β-sheet and all strands except one are 
antiparallel.  One face of the twisted β-sheet is covered with helices G and C, whereas the other solvent 
accessible β-sheet forms a pocket lined with helices F and H.  Domain 2 encompasses secondary 
structural elements that interact with their symmetric counterparts in the other monomer 23.  Within this 
domain, three strands from each monomer form a 6-stranded antiparallel β-sheet across the dimer 
interface.  Helices D and E of each monomer form a four-helix bundle across the homodimer interface, 
and the helical axes are roughly parallel to the 2-fold axis relating both monomers.  Domain 3 contains a 
5-stranded mixed β-sheet located between helices J and M on one side and a β-hairpin (formed by two 
other strands) and helix K on the other side.  Based on the crystal structure of the mouse p55, Gly451 in 
the human protein is located on the inner face of domain 3 and is not involved in homo-dimerization of 
the accessory subunit (Fig. 8).  Accordingly, the G451E substitution in human p55 is unlikely to prevent 
heterodimerization of G451E p55 and WT p55.  However, deletion of 30 residues near the C-terminus of 
p55 (deletion of a.a. 456-485) disturbs the inner face of domain 3 and prevents interaction with p140 in 
electrophoretic mobility shift assays 26, suggesting that this portion of p55 constitutes part of the interface 
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with the catalytic subunit.  Also, recent biochemical evidence demonstrates that the human p55 
homodimer associates with the catalytic subunit to form a 1:2 heterotrimer (p140:p55:p55) 24.  The 
dissociation constant for p55 homodimers is very low (< 0.1 nM) 24.  This predicts that G451E and WT 
p55 monomers did not exchange during our in vitro mixing experiments, which prevented us from 
measuring any dominant negative effect in vitro.  Although factors affecting assembly of the pol γ 
holoenzyme following importation of the subunits into mitochondria are not well studied, in vivo 
heterodimerization of G451E and WT p55 remains a distinct possibility.  By extension, only one fourth 
of the pol γ heterotrimers in individuals heterozygous for POLG2 would be wild type, which may 
compromise mtDNA replication even more effectively than simple haplotype insufficiency. 
 In summary we have described the first pathogenic mutation in POLG2 that causes a disorder of 
mtDNA maintenance.  The G451E mutation disrupts interaction between the accessory subunit and the 
catalytic subunit, ultimately causing the multiple deletions in the mtDNA of this patient.  We therefore 
believe POLG2 should be included when searching for nuclear genes with mutations that cause disorders 
of mtDNA maintenance, especially when POLG, C10orf2, ANT1, TK, DGUOK, and TP are determined 
to have wild type sequences in affected patients. 
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Figure Legends 
 
Fig. 1.  Skeletal muscle histochemistry and mtDNA analysis.  (A) Dual COX-SDH histochemistry 
(see Subjects and Methods) showing a mosaic distribution of COX deficient muscle fibers (blue) 
amongst fibers with normal COX activity (brown).  (B) Long range PCR of skeletal muscle mtDNA 
(extracted from a tissue homogenate).  Lane 1, 1kb ladder; lane 2, young control muscle; lane 3, age-
matched control muscle; lane 4, patient muscle showing multiple mtDNA deletions.  (C) Real-time PCR 
analysis of COX negative muscle fibers.  The majority of fibers contain high percentage levels of 
mtDNA deletions which remove the ND4 region (see Subjects and Methods). 
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Fig. 2.  A novel mutation in POLG2.  (A) Pedigree of the proband (II-2, arrow) and her unaffected 
siblings.  (B) Sequence traces show a heterozygous base substitution in the proband which is absent in 
her unaffected sisters.  (C) DHPLC traces for an exon 8 amplicon from the proband (upper) and control 
individual (lower).  (D) Amino acid conservation across species in exon 8 of POLG2, with codon 451 
identified in red. 
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Fig. 3.  Effects of WT p55 and G451E p55 on pol γ polymerase activity.  DNA polymerase activity 
was measured on poly(rA)•oligo(dT) as described in Subjects and Methods.  Reactions contained 12 ng 
(88 fmol) p140, either alone (squares) or with 9.6 ng (178 fmol) of WT p55 (triangles) or G451E p55 
(circles), and the indicated amounts of NaCl.  Values are the average of two independent measurements. 
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Fig. 4.  Analysis of pol γ subunits by analytical single-stranded DNA-cellulose chromatography.  
Purified recombinant p140, WT p55, and G451E p55 were resolved by single-stranded DNA-cellulose 
chromatography as described in Subjects and Methods.  Elution of proteins from the column was 
monitored by absorbance at 280 nm.  (A) WT p55 (dashed line), G451E p55 (solid line), or p140 (dotted 
line) were applied separately and eluted with a NaCl gradient.  (B) The p140 catalytic subunit (29 µg) 
was mixed with 31 µg WT p55 (dashed line) or 27 µg G451E p55 (solid line) and eluted as before.  
Samples of the indicated fractions of the p140•WT p55 profile (C) and the p140•G451E p55 profile (D) 
were resolved by SDS-PAGE and stained with Coomassie Brilliant Blue, as described in Subjects and 
Methods.  Arrows indicate the individual migration positions of p140 and p55 (C) and (D). 
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Fig. 5.  G451E p55 only partially protects p140 against inactivation by N-ethylmaleimide.  DNA 
polymerase activity was measured as described in Subjects and Methods, except 2-mercaptoethanol was 
excluded.  Reactions contained 75 mM NaCl, 8.0 ng (58 fmol) p140 either alone (squares) or in the 
presence of 6.3 ng (116 fmol) WT p55 (triangles) or G451E p55 (circles), and the indicated amounts of 
NEM.  Values are the average of at least two independent measurements. 
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Fig. 6.  G451E p55 fails to co-immunoprecipitate with p140.  The p140-dependent co-
immunoprecipitation of WT p55 or G451E p55 with immobilized anti-p140 rabbit antibodies was 
assayed as described in Subjects and Methods.  Samples contained WT p55 alone (lane 1), p140 catalytic 
subunit and WT p55 (lane 2), G451E mutant p55 (lane 3), p140 and G451E mutant p55 (lane 4), or 0.2 
µg each of p140 and p55 loaded directly as positive controls for the Western (lane 5).  The positions of 
p140 and p55 standards are indicated with arrows. 
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Fig. 7.  G451E p55 does not enhance processive DNA synthesis of pol γ.  Primer extension reactions 
were performed as described in Subjects and Methods.  Reactions contained p140 catalytic subunit (lanes 
1-6), WT p55 (lanes 3 and 4), G451E p55 (lanes 5-6), and singly primed M13 DNA.  Activity was 
measured at 0 mM NaCl (odd numbered lanes) or 150 mM NaCl (even numbered lanes).  Lane 0 had no 
enzyme.  Reaction products were resolved by denaturing polyacrylamide gel electrophoresis (A) and 
alkaline agarose gel electrophoresis (B).  The arrows in A and B mark the unextended 35-mer primer.  
Markers indicate the number of nucleotides synthesized past the primer. 
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Fig. 8.  Homologous position of the G451E side chain on the ribbon structure of the homodimeric 
mouse accessory subunit.  The ribbon drawing was generated with Swiss PDB viewer from Protein 
Data Bank file 1G5H. 23  Each monomer is colored either blue or red.  Amino acids in domains 1 and 2 
constitute the dimer interfaces, which are far removed from the homologous position of the G451E 
substitution in human PEO (arrows). 
 
